Glenmark Pharma Recovers After Mgmt Says Margin Will Improve & They See Strong US Biz In FY27

Описание: Q2 With CNBC TV18 | Glenmark Pharmaceuticals makes a recovery post its management commentary

Margin to improve to 23% and then 25%

Mgmt also highlights that FY27 should be a strong year for the US biz


#glenmark #glenmarkpharma #ebitda #margin #netprofit #q2earnings #q2results #q2fy26 #q2fy26results #q2fy26earnings #q2withcnbctv18 #stockmarket #stockmarketnews #stockmarketupdates #cnbctv18market #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday

🔴CNBC TV18 LIVE TV: https://youtube.com/live/P857H4ej-MQ
SUBSCRIBE to our Channel: https://bit.ly/3nvEcxf
---------------------------------------------------------------------------------------------------------------------
👑 Check Out Top CNBC TV18 Playlist Videos:
🔹Young Turks Reloaded with Shereen Bhan:    • Young Turks Reloaded with Shereen Bhan  
🔹CNBC TV18 Global Lens:    • CNBC TV18 Prime | Global Lens  
🔹 World News:    • World News 2025 | Latest International News  
🔹CNBC TV18 Classic Interviews:    • CNBC-TV18 Classics  
🔹Overdrive Show:    • OVERDRIVE || CNBC TV18  
🔹Startup Streets:    • Startup Street  

------------------------------------------------------------------------------------
You can also connect with CNBC-TV18 News Online
Catch the latest news: https://bit.ly/2YbpXBM

Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/

Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/
You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/
Like us on Facebook:   / cnbctv18india  
Follow us on Twitter:   / cnbctv18news  
Follow us on Instagram:   / cnbctv18india  
Catch us on: Linkedin:   / cnbc-tv18  
n18oc_business
About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here.